Evidence map›Paper›PMID 31451869›Full record

ReviewDiabetologia2019

Environmental neglect: endocrine disruptors as underappreciated but potentially modifiable diabetes risk factors.

Robert M Sargis, Rebecca A Simmons

Open access · bronzeAbstract readReview
In one paragraph

Review in Diabetologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 137 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Determinants of obesity in Latin America.Nature metabolism · 2024 · on this map
    Review
  18. Article
  19. Review
  20. Endocrine disruptors in plastics alter β-cell physiology and increase the risk of diabetes mellitus.American journal of physiology. Endocrinology and metabolism · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Robert M SargisDivision of Endocrinology, Diabetes, and Metabolism Department of Medicine, University of Illinois at Chicago, 835 S. Wolcott, Suite E625; M/C 640, Chicago, IL, 60612, USA. rsargis@uic.edu.
Rebecca A SimmonsDivision of Neonatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
University of Illinois Chicago · USUniversity of Pennsylvania · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2006 to 2026
$35.3M
Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
Selenoproteins in Arsenic-Induced Metabolic DysfunctionR01ES028879 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SARGIS, ROBERT M · 2018 to 2022
$2.7M
Persistent Organic Pollutants, Endogenous Hormones and Diabetes in LatinosR01ES025159 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PERSKY, VICTORIA W · 2016 to 2019
$2.5M
Preconception phthalate exposure and offspring outcomesR01ES028206 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S., SIMMONS, REBECCA A · 2017 to 2021
$2.3M
Transgenerational effects of endocrine disruptors: epigenetics and physiologyR01ES023284 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S., SIMMONS, REBECCA A · 2013 to 2017
$2.1M
NIEHS NIH HHS P30 ES013508NIEHS NIH HHS P30 ES027792NIEHS NIH HHS R01 ES023284NIEHS NIH HHS R01 ES025159NIEHS NIH HHS R01 ES028206NIEHS NIH HHS R01 ES028879
6 · The paper itself

Abstract

Type 2 diabetes prevalence is increasing dramatically across the globe, imposing a tremendous toll on individuals and healthcare systems. Reversing these trends requires comprehensive approaches to address both classical and emerging diabetes risk factors. Recently, environmental toxicants acting as endocrine-disrupting chemicals (EDCs) have emerged as novel metabolic disease risk factors. EDCs implicated in diabetes pathogenesis include various inorganic and organic molecules of both natural and synthetic origin, including arsenic, bisphenol A, phthalates, polychlorinated biphenyls and organochlorine pesticides. Indeed, evidence implicates EDC exposures across the lifespan in metabolic dysfunction; moreover, specific developmental windows exhibit enhanced sensitivity to EDC-induced metabolic disruption, with potential impacts across generations. Importantly, differential exposures to diabetogenic EDCs likely also contribute to racial/ethnic and economic disparities. Despite these emerging links, clinical practice guidelines fail to address this underappreciated diabetes risk factor. Comprehensive approaches to stem the tide of diabetes must include efforts to address its environmental drivers.

Indexed as

Benzhydryl CompoundsBisphenol A CompoundsDiabetes Mellitus, Type 2Endocrine DisruptorsEnvironmental PollutantsHumansPhenolsPhthalic AcidsRisk FactorsBenzhydryl Compoundsbisphenol ABisphenol A CompoundsEndocrine DisruptorsEnvironmental PollutantsPhenolsphthalic acidPhthalic AcidsBeta cellBisphenol ADiabetesEndocrine-disrupting chemicalEndocrine disruptorEnvironmental justiceGlucoseInsulinLife course developmentReview

Identifiers

PMID31451869
PMCPMC7462102
OpenAlexW2970657072

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.